Cargando…
CREB1(K292) and HINFP(K330) as Putative Common Therapeutic Targets in Alzheimer’s and Parkinson’s Disease
[Image: see text] Integration of omics data and deciphering the mechanism of a biological regulatory network could be a promising approach to reveal the molecular mechanism involved in the progression of complex diseases, including Alzheimer’s and Parkinson’s. Despite having an overlapping mechanism...
Autores principales: | Gupta, Rohan, Kumar, Pravir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717564/ https://www.ncbi.nlm.nih.gov/pubmed/34984308 http://dx.doi.org/10.1021/acsomega.1c05827 |
Ejemplares similares
-
Computational Analysis Indicates That PARP1 Acts as
a Histone Deacetylases Interactor Sharing Common Lysine Residues for
Acetylation, Ubiquitination, and SUMOylation in Alzheimer’s
and Parkinson’s Disease
por: Gupta, Rohan, et al.
Publicado: (2021) -
p38 MAPK and PI3K/AKT Signalling Cascades inParkinson’s Disease
por: Jha, Saurabh Kumar, et al.
Publicado: (2015) -
Identification and characterization of putative biomarkers and therapeutic axis in Glioblastoma multiforme microenvironment
por: Kumari, Smita, et al.
Publicado: (2023) -
Therapeutic Targeting of Repurposed Anticancer Drugs
in Alzheimer’s Disease: Using the Multiomics Approach
por: Advani, Dia, et al.
Publicado: (2021) -
In silico designing of putative peptides for targeting pathological protein Htt in Huntington's disease
por: Kohli, Harleen, et al.
Publicado: (2021)